Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 18,980 |
|
|||||
| News | - | ||||||
| Day High | 7.56 | Low High |
|||||
| Day Low | 7.31 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aura Biosciences Inc | AURA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.045 | 0.61% | 7.405 | 10:50:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.46 | 7.31 | 7.56 | 7.36 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 285 | 18,980 | $ 7.43 | $ 141,113 | - | 5.99 - 13.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:50:38 | 1 | $ 7.405 | USD |
Aura Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 283.89M | 38.26M | - | 0 | -76.41M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aura Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AURA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.29 | 7.84 | 6.9625 | 7.44 | 373,683 | 0.115 | 1.58% |
| 1 Month | 7.97 | 8.07 | 6.64 | 7.35 | 195,008 | -0.565 | -7.09% |
| 3 Months | 8.38 | 8.74 | 6.64 | 7.44 | 204,661 | -0.975 | -11.63% |
| 6 Months | 8.20 | 9.72 | 6.64 | 7.95 | 176,766 | -0.795 | -9.70% |
| 1 Year | 11.99 | 13.50 | 5.99 | 8.49 | 148,611 | -4.59 | -38.24% |
| 3 Years | 14.10 | 26.16 | 5.99 | 11.23 | 113,972 | -6.70 | -47.48% |
| 5 Years | 14.10 | 26.16 | 5.99 | 11.23 | 113,972 | -6.70 | -47.48% |
Aura Biosciences Description
| Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. |
